Furthermore, the ability of anti-PD-L1 rFab’ to sensitize FaDu and SCC-011 cells to Cis-Pt (1 μM) was evaluated by a clonogenic assay, which showed that clone proliferation was drastically reduced when tumor cells were treated with both drugs (Fig. 10B). This evidence concerns the gene CD274 and neoplasm.